Half-life revisited: implication in clinical trials and bioavailability/bioequivalence evaluation.
Chen
M L
ML
Pelsor
F R
FR
D001682:Biological Availability; D002986:Clinical Trials as Topic / Q000379:methods; D006207:Half-Life; D010599:Pharmacokinetics; D013810:Therapeutic Equivalency